TJX Stock Rises Pre-Market After Earnings Forecast Hike On Strong Holiday Demand
The company now expects fiscal 2026 earnings per share to be in the range of $4.63 to $4.66, compared with the previous forecast of $4.52 to $4.57.
Stocktwits·1d ago
More News
Microsoft Introduces 'Agent 365' To Track AI Agents Within Systems
Microsoft noted that unmanaged agents can turn into invisible threats that leak data or take unauthorized actions, undermining a company’s security, governance, and compliance framework.
Stocktwits·2d ago
HD Stock Drops Premarket On Lower Profit Guidance – CEO Says Demand Uptick Did Not Arrive
Home Depot now expects adjusted earnings per share to decline approximately 5%, compared with the prior forecast of a 2% fall.
Stocktwits·2d ago
BMY Stock Slumps 4% After It Scraps Heart Drug Study
The decision follows an analysis by an independent data monitoring committee that the trial is unlikely to meet its key goal.
Stocktwits·6d ago
Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV
The company now plans to submit the data from the study to regulatory authorities.
Stocktwits·7d ago
General Motors Races To Decouple Supply Chain From China: Report
Reuters on Wednesday reported, citing four people familiar with the matter, that GM executives have been telling suppliers to find alternatives besides China for raw materials and parts.
Stocktwits·8d ago
Johnson & Johnson’s Newly Acquired Antipsychotic Drug Approved By FDA For Major Depressive Disorder
JNJ gained access to Caplyta with the $14.6 billion acquisition of Intra-Cellular Therapies, Inc., which closed in April.
Stocktwits·14d ago
Cencora Announces $1B Investment In US After Q4 Numbers Beat Estimates
The company will open its second national distribution center in Ohio and expand its presence in both Alabama and California, it said.
Stocktwits·15d ago
Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug
The deal will fund a portion of the development costs for Sacituzumab Tirumotecan, also known as Sac-TMT.
Stocktwits·16d ago
Apple Reportedly Developing Budget Mac To Take On Low-Cost Chromebooks, Windows PCs
According to a Bloomberg News report, citing people familiar with the matter, the new low-cost laptop would be developed for students, businesses, and casual users.